Brain Mapping as Helpful Tool in Brain Glioma Surgical Treatment-Toward the "Perfect Surgery"?
- PMID: 30373168
- PMCID: PMC6266076
- DOI: 10.3390/brainsci8110192
Brain Mapping as Helpful Tool in Brain Glioma Surgical Treatment-Toward the "Perfect Surgery"?
Abstract
Gliomas are the most common primary malignant brain tumours in adults, representing nearly 80%, with poor prognosis in their high-grade forms. Several variables positively affect the prognosis of patients with high-grade glioma: young age, tumour location, radiological features, recurrence, and the opportunity to perform post-operative adjuvant therapy. Low-grade gliomas are slow-growing brain neoplasms of adolescence and young-adulthood, preferentially involving functional areas, particularly the eloquent ones. It has been demonstrated that early surgery and higher extent rate ensure overall longer survival time regardless of tumour grading, but nowadays, functional preservation that is as complete as possible is imperative. To achieve the best surgical results, along with the best functional results, intraoperative mapping and monitoring of brain functions, as well as different anaesthesiology protocols for awake surgery are nowadays being widely adopted. We report on our experience at our institution with 28 patients affected by malignant brain tumours who underwent brain mapping-aided surgical resection of neoplasm: 20 patients underwent awake surgical resection and 8 patients underwent asleep surgical resection. An analysis of the results and a review of the literature has been performed.
Keywords: asleep surgery; awake surgery; brain mapping; brain tumour; extent of resection; high grade glioma; low grade glioma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Lacroix M., Abi-Said D., Fourney D.R., Gokaslan Z.L., Shi W., DeMonte F., Lang F.F., McCutcheon I.E., Hassenbusch S.J., Holland E., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J. Neurosurg. 2001;95:190–198. doi: 10.3171/jns.2001.95.2.0190. - DOI - PubMed
-
- Lote K., Egeland T., Hager B., Stenwig B., Skullerud K., Berg-Johnsen J., Storm-Mathisen I., Hirschberg H. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: A retrospective study in 379 patients. J. Clin. Oncol. 1997;15:3129–3140. doi: 10.1200/JCO.1997.15.9.3129. - DOI - PubMed
-
- La Torre D., Maugeri R., Angileri F.F., Pezzino G., Conti A., Cardali S.M., Calisto A., Sciarrone G., Misefari A., Germanò A., et al. Human leukocyte antigen frequency in human high-grade gliomas: A case-control study in Sicily. Neurosurgery. 2009;64:1082–1089. doi: 10.1227/01.NEU.0000345946.35786.92. - DOI - PubMed
LinkOut - more resources
Full Text Sources
